Skip to main content

Lambda Light Chain Antibody (RM110) [Biotin]

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-62002B

Recombinant Monoclonal Antibody.
Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-62002B

Key Product Details

Species Reactivity

Mouse

Applications

ELISA, Western Blot

Label

Biotin

Antibody Source

Recombinant Monoclonal Rabbit IgG Clone # RM110

Concentration

1 mg/ml

Product Specifications

Immunogen

Mouse IgM Lambda

Specificity

This antibody reacts to the lambda light chain of mouse immunoglobulins. No cross reactivity with the kappa light chain, human IgG, rat IgG, or goat IgG.

Clonality

Monoclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for Lambda Light Chain Antibody (RM110) [Biotin]

Western Blot: Rabbit anti-Mouse Lambda Light Chain Secondary Antibody (RM110) [Biotin] [NBP2-62002B] - Western blot of nonreduced(-) and reduced(+) mouse IgG1(kappa) and IgG1(lambda) (20ng/lane), using0.2ug/mL of NBP2-62002B. This antibody reacts to nonreduced IgG1(Lambda).
ELISA: Rabbit anti-Mouse Lambda Light Chain Secondary Antibody (RM110) [Biotin] [NBP2-62002B] - ELISA of mouse immunoglobulins shows NBP2-62002B reacts to the lambda light chain of mouse immuno-globulins. No cross reactivity with the kappa light chain, human IgG, rat IgG, or goat IgG. The plate was coated with different immuno-globulins. NBP2-62002B was used as the primary antibody. An alkaline phosphatase conjugated anti-rabbit IgG as the secondary antibody.
ELISA: Rabbit anti-Mouse Lambda Light Chain Secondary Antibody (RM110) [Biotin] [NBP2-62002B] - A titer ELISA of mouse IgG1 lambda. The plate was coated with different amounts of mouse IgG1 lambda. A serial dilution of NBP2-62002B was used as the primary antibody. An alkaline phosphatase conjugated anti-rabbit IgG as the secondary antibody.

Applications for Lambda Light Chain Antibody (RM110) [Biotin]

Application
Recommended Usage

ELISA

0.005 ug/ml - 0.2 ug/ml

Western Blot

0.1 - 0.5 ug/mL
Application Notes
This primary antibody can also be used as a secondary antibody.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS, 50% Glycerol, 1% BSA

Preservative

0.09% Sodium Azide

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: Lambda Light Chain

All five immunoglobulin classes share the same basic four polypeptide chain structure of two heavy-chains and two light chains. There are five heavy chain types, and two light-chain types (Kappa and Lambda) both having a molecular weight of 22.5kDa. Any heavy-chain type can associate with either light-chain type, but on any immunoglobulin molecule both light-chains are of the same type. Kappa and Lambda consist of a variable region and a constant region and can easily be differentiated by the antigenic properties of the constant region. The ratio of Kappa to Lambda is 70:30 , the vast majority of which is bound to heavy-chain in immunoglobulin. In normal individuals low levels of free light-chain arepresent in serum (kappa, 1.6-15.2 mg/L; Lambda, 0.4-4.2mg/L), with the occurrence of multiple myeloma or other B-cell malignancies these levels can be greatly elevated and can be found at high levels in the urine (Bence-Jones proteins). This antibody stains only lambda light chain containing cells in human lymphoid tissues.

Alternate Names

IGLC, immunoglobulin lambda constant group

Gene Symbol

IGLC1

Additional Lambda Light Chain Products

Product Documents for Lambda Light Chain Antibody (RM110) [Biotin]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Lambda Light Chain Antibody (RM110) [Biotin]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...